2021
DOI: 10.1016/j.ijbiomac.2021.02.043
|View full text |Cite
|
Sign up to set email alerts
|

The nuclear transporter importin-11 regulates the Wnt/β-catenin pathway and acts as a tumor promoter in glioma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 37 publications
0
4
0
Order By: Relevance
“…In addition, LASS2 has been demonstrated to promote tumor cell apoptosis via ceramide [24,25], an effect that can be reduced when ceramide is converted into survival-promoting sphingosine 1-phosphate (S1P) by sphingosine kinase 1 (SPHK1) in glioblastoma [26,27]. Overexpression of LASS2 reduced the protein expression of SPHK1, MMP9, MMP2, Bcl-2, Vimentin, and N-cadherin while increasing that of TIMP2, Bax, activated caspase3, TNF-α, p53, and E-cadherin both in vitro and in vivo, suggesting that LASS2 suppresses the development and progression of glioma mainly by inhibiting tumor cell migration, invasion, and proliferation [28][29][30]. The inhibitory effect of LASS2 on subcutaneous xenograft growth further supports previous reports that LASS2 can function as a novel tumor-suppressing gene in glioma formation, progression, and metastasis.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, LASS2 has been demonstrated to promote tumor cell apoptosis via ceramide [24,25], an effect that can be reduced when ceramide is converted into survival-promoting sphingosine 1-phosphate (S1P) by sphingosine kinase 1 (SPHK1) in glioblastoma [26,27]. Overexpression of LASS2 reduced the protein expression of SPHK1, MMP9, MMP2, Bcl-2, Vimentin, and N-cadherin while increasing that of TIMP2, Bax, activated caspase3, TNF-α, p53, and E-cadherin both in vitro and in vivo, suggesting that LASS2 suppresses the development and progression of glioma mainly by inhibiting tumor cell migration, invasion, and proliferation [28][29][30]. The inhibitory effect of LASS2 on subcutaneous xenograft growth further supports previous reports that LASS2 can function as a novel tumor-suppressing gene in glioma formation, progression, and metastasis.…”
Section: Discussionmentioning
confidence: 99%
“…Wnt/β-catenin signaling pathway participates in the regulation of tumor cell growth and differentiation, and activation of Wnt/β-catenin signaling pathway can participate in the process and metastasis of glioma cells [19,20]. Studies revealed that inhibiting the Wnt/β-catenin signaling pathway can inhibit the proliferation and migration of glioma cells [21].…”
Section: Discussionmentioning
confidence: 99%
“…Alternatively, Lgs/BCL9 has been suggested to escort beta-catenin into the nucleus where both proteins are anchored through interactions with Pygopus (Townsley et al, 2004). More recently, a role for importins was identified in glioma cells, where depletion of importin-11 resulted in a cytosolic shift in the nuclear-cytoplasmic beta-catenin distribution, suggesting importins could regulate nuclear bcatenin levels during tumorigenesis (Ni et al, 2021). Similarly, we report a SYS-1 interaction with importin b IMB-3 suggesting the hypothesis that conserved importin interactions may lead to SYS-1 nuclear translocation.…”
Section: Discussionmentioning
confidence: 99%